Skip to main content
. 2022 Aug 26;23(17):9686. doi: 10.3390/ijms23179686

Table 1.

REDD1 role in cancer.

Specific Hallmark of Cancer REDD1 Role Effect References
Evasion from growth inhibition N/D * N/D N/D
Sustaining proliferation REDD1 inhibited proliferation in vitro and in vivo Anti-cancer [8,18,24,46,49,50,62,63]
Attenuation of apoptosis REDD1 expression was correlated with abrogation of apoptosis Pro-oncogenic [1,64,65,66,67]
Stimulation of neo-angiogenesis REDD1 overexpression was correlated with blood vessel density and slower angiogenesis rate in oral squamous carcinoma Anti-cancer [56]
REDD1 induced angiogenesis in glioblastoma, colon, and lung cancer cells Pro-oncogenic [70,71,72,73,74,75,76]
Escape from immune response REDD1 promoted tumor escape from immune system Pro-oncogenic [73,80]
Immortalization N/D N/D N/D
Tumor-associated inflammation REDD1 deficiency blunted response to LPS, attenuated production of pro-inflammatory cytokines, and reduced inflammation Pro-oncogenic [94,95]
Genetic instability N/D N/D N/D
Invasion and metastasis REDD1 overexpression in TAM was associated with metastasis induction Pro-oncogenic [55,78]
Metabolic shift REDD1 depleted intracellular ATP, stimulated ROS-mediated cytotoxicity, and decreased glucose uptake Anti-cancer [18,20,21,22]
Cell senescence REDD1 promoted pro-survival autophagy in thymocytes Pro-oncogenic [64,87]
Cellular plasticity REDD1 overexpression blocked keratinocyte differentiation Pro-oncogenic [1,18]
Non-mutational epigenetic reprogramming REDD1 may cause changes in methylation pattern Questionable [88]
Microbiome polymorphism N/D N/D N/D

* N/D, not described.